They found that 36% of these men had clinically low levels of phosphate in their blood, as opposed to the approximate 2–4% incidence found in the general population in Denmark.

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show ...